Nutex Health, Inc. (NUTX) Stock Forecast & Price Target

Nutex Health, Inc. (NUTX) has an ST Score of 69.1 out of 100, an overall grade of B+. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Wall Street's consensus rating on NUTX is Buy based on 4 analyst ratings. Our own ST Score grades it B+ (69.1/100). This is data, not investment advice — always do your own research.

Nutex Health, Inc. (NUTX) earns a valuation grade of C, measured against Medical - Care Facilities peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

Nutex Health, Inc. (NUTX) earns a growth grade of B, measured against Medical - Care Facilities peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

Nutex Health, Inc. (NUTX) earns a profitability grade of A+, measured against Medical - Care Facilities peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

Nutex Health, Inc. (NUTX) earns a financial strength grade of A-, measured against Medical - Care Facilities peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

The average analyst price target for Nutex Health, Inc. (NUTX) is $310.00 from 4 analysts, which is +0.5% versus the recent price of $204.59.

Nutex Health, Inc. (NUTX) has a Piotroski F-Score of 6 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.